Evolent Health Newsroom

J.P. Morgan Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $15

Futu NewsNov 22 20:32

Oppenheimer Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $28

Futu NewsNov 19 16:37

Evolent Health Is Maintained at Outperform by Oppenheimer

Dow JonesNov 18 22:09

Oppenheimer Maintains Outperform on Evolent Health, Lowers Price Target to $28

BenzingaNov 18 22:00

Evolent Health Analyst Ratings

BenzingaNov 18 21:59

Citi Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $21

Futu NewsNov 13 20:31

RBC Capital Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $20

Futu NewsNov 13 14:31

Evolent Health Price Target Maintained With a $20.00/Share by RBC Capital

Dow JonesNov 12 23:50

A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $19 to $36

Futu NewsNov 12 21:04

RBC Capital Sticks to Its Buy Rating for Evolent Health (EVH)

TipRanksNov 12 19:38

Evolent Health Is Maintained at Overweight by Barclays

Dow JonesNov 11 22:17

Evolent Health Analyst Ratings

BenzingaNov 11 22:08

Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $24

Futu NewsNov 11 20:34

Barclays Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $19

Futu NewsNov 11 16:34

A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $27 to $63

Futu NewsNov 9 21:10

Evolent Health Is Maintained at Outperform by Oppenheimer

Dow JonesNov 9 00:21

RBC Capital Adjusts Evolent Health Price Target to $20 From $42, Maintains Outperform Rating

MT NewswiresNov 8 23:03

Evolent Health Analyst Ratings

BenzingaNov 8 20:17

Stephens & Co. Downgrades Evolent Health to Equal-Weight, Announces $16 Price Target

BenzingaNov 8 20:17

Barclays Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $39

Futu NewsNov 8 18:37